AstraZeneca contributes to global rescue effort for Haiti

Wednesday, 13 January 2010

AstraZeneca is contributing to the global rescue effort in the wake of Haiti’s devastating earthquake. We have donated antibiotic and respiratory medicines (Meronem, Pulmicort and Rhinocort) through US charity AmeriCares and through Health Partners International in Canada, cardiovascular, gastrointestinal and respiratory (Tenormin, Losec, Nexium, Bricanyl, Pulmicort Turbuhaler) medicines.

In addition to our initial donation of $160,000, we have now donated a further $340,000 to the British Red Cross Emergency Appeal. We have also committed an additional $500,000 to support a longer-term disaster recovery programme that will give the people of Haiti the help they need to re-build their lives and their communities. We are currently working with AstraZeneca colleagues in the region to identify appropriate projects and partners.

LabTalk is AstraZeneca’s science-focused blog where you can hear from scientists, researchers and academics discussing novel ideas, research and innovation.

David_Andrews_THM 24 November 2014

AstraZeneca Scientist is Appointed as Royal Society of Chemistry Industrial Associate to Advance Open Innovation

Collab_in_practice_THM 20 November 2014

Collaboration in practice – partnering to accelerate drug discovery

Outcomes_trials_THM 14 November 2014

Outcomes trials: the foundation of evidence-based cardiovascular medicine